SymBiosis Capital Partners, LLC

Position in SRZN — Surrozen, Inc./DE

CIK 2006045 BENTONVILLE, AR

Position in SRZN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

+$0 QoQ

Shares Held

150,000

0.0% QoQ

Ownership

1.28%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

SymBiosis Capital Partners, LLC holds $50,642,960 across 5 Biotechnology names. SRZN ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc.	1,280,778	$29,445,086
2	IVA	Inventiva S.A.	2,354,000	$13,064,700
3	WVE	Wave Life Sciences, Inc.	750,000	$5,437,500
4	RANI	Rani Therapeutics Holdings, Inc.	3,667,585	$2,695,674
5	SRZN	Surrozen, Inc./DE This page	150,000	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31 SRZNW	—	150,000	0.0%	Shares	Sole	2026-05-12
2025-12-31 SRZNW	—	150,000	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.